Structure-activity relationship studies of central nervous system agents. 13. 4-[3-(Benzotriazol-1-yl)propyl]-1-(2-methoxyphenyl)piperazine, a new putative 5-HT1A receptor antagonist, and its analogs. 1994

J L Mokrosz, and M H Paluchowska, and E Chojnacka-Wójcik, and M Filip, and S Charakchieva-Minol, and A Dereń-Wesołek, and M J Mokrosz
Department of Medicinal Chemistry, Polish Academy of Sciences, Kraków.

A new set of 4-alkyl-1-(o-methoxyphenyl)piperazines containing a terminal benzotriazole fragment were synthesized, and their 5-HT1A and 5-HT2 affinity was determined. It was shown that the benzotriazole moiety contributes to both the 5-HT1A and 5-HT2 receptor affinity. It was demonstrated in several behavioral models that 4-[3-(benzotriazol-1- yl)propyl]-1-(2-methoxyphenyl)piperazine (11) is a new, potent presynaptic and postsynaptic 5-HT1A receptor antagonist. However, it is not selective for 5-HT1A versus alpha 1 receptors.

UI MeSH Term Description Entries
D007202 Indicators and Reagents Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant & Hackh's Chemical Dictionary, 5th ed, p301, p499) Indicator,Reagent,Reagents,Indicators,Reagents and Indicators
D009043 Motor Activity Body movements of a human or an animal as a behavioral phenomenon. Activities, Motor,Activity, Motor,Motor Activities
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D010879 Piperazines Compounds that are derived from PIPERAZINE.
D011187 Posture The position or physical attitude of the body. Postures
D011869 Radioligand Assay Quantitative determination of receptor (binding) proteins in body fluids or tissue using radioactively labeled binding reagents (e.g., antibodies, intracellular receptors, plasma binders). Protein-Binding Radioassay,Radioreceptor Assay,Assay, Radioligand,Assay, Radioreceptor,Assays, Radioligand,Assays, Radioreceptor,Protein Binding Radioassay,Protein-Binding Radioassays,Radioassay, Protein-Binding,Radioassays, Protein-Binding,Radioligand Assays,Radioreceptor Assays
D012110 Reserpine An alkaloid found in the roots of Rauwolfia serpentina and R. vomitoria. Reserpine inhibits the uptake of norepinephrine into storage vesicles resulting in depletion of catecholamines and serotonin from central and peripheral axon terminals. It has been used as an antihypertensive and an antipsychotic as well as a research tool, but its adverse effects limit its clinical use. Raunervil,Raupasil,Rausedil,Rausedyl,Serpasil,Serpivite,V-Serp,V Serp
D001833 Body Temperature Regulation The processes of heating and cooling that an organism uses to control its temperature. Heat Loss,Thermoregulation,Regulation, Body Temperature,Temperature Regulation, Body,Body Temperature Regulations,Heat Losses,Loss, Heat,Losses, Heat,Regulations, Body Temperature,Temperature Regulations, Body,Thermoregulations
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

J L Mokrosz, and M H Paluchowska, and E Chojnacka-Wójcik, and M Filip, and S Charakchieva-Minol, and A Dereń-Wesołek, and M J Mokrosz
October 1966, Indian journal of physiology and pharmacology,
J L Mokrosz, and M H Paluchowska, and E Chojnacka-Wójcik, and M Filip, and S Charakchieva-Minol, and A Dereń-Wesołek, and M J Mokrosz
June 1992, Journal of medicinal chemistry,
J L Mokrosz, and M H Paluchowska, and E Chojnacka-Wójcik, and M Filip, and S Charakchieva-Minol, and A Dereń-Wesołek, and M J Mokrosz
April 1995, Journal of medicinal chemistry,
J L Mokrosz, and M H Paluchowska, and E Chojnacka-Wójcik, and M Filip, and S Charakchieva-Minol, and A Dereń-Wesołek, and M J Mokrosz
February 1996, Die Pharmazie,
J L Mokrosz, and M H Paluchowska, and E Chojnacka-Wójcik, and M Filip, and S Charakchieva-Minol, and A Dereń-Wesołek, and M J Mokrosz
April 1995, Archiv der Pharmazie,
J L Mokrosz, and M H Paluchowska, and E Chojnacka-Wójcik, and M Filip, and S Charakchieva-Minol, and A Dereń-Wesołek, and M J Mokrosz
August 1991, Journal of medicinal chemistry,
J L Mokrosz, and M H Paluchowska, and E Chojnacka-Wójcik, and M Filip, and S Charakchieva-Minol, and A Dereń-Wesołek, and M J Mokrosz
January 1994, Journal of medicinal chemistry,
J L Mokrosz, and M H Paluchowska, and E Chojnacka-Wójcik, and M Filip, and S Charakchieva-Minol, and A Dereń-Wesołek, and M J Mokrosz
October 1989, European journal of pharmacology,
J L Mokrosz, and M H Paluchowska, and E Chojnacka-Wójcik, and M Filip, and S Charakchieva-Minol, and A Dereń-Wesołek, and M J Mokrosz
October 1996, Journal of medicinal chemistry,
J L Mokrosz, and M H Paluchowska, and E Chojnacka-Wójcik, and M Filip, and S Charakchieva-Minol, and A Dereń-Wesołek, and M J Mokrosz
December 2009, Journal of medicinal chemistry,
Copied contents to your clipboard!